Shanghai - Delayed Quote • CNY
Liaoning Chengda Biotechnology Co.,Ltd. (688739.SS)
As of 1:53 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,750,103.09
1,750,103.09
1,814,998.63
2,088,043.47
1,995,575.51
Cost of Revenue
286,150.20
286,150.20
233,889.73
211,913.42
274,323.25
Gross Profit
1,463,952.89
1,463,952.89
1,581,108.90
1,876,130.05
1,721,252.27
Operating Expense
871,215.02
871,215.02
802,698.80
848,439.52
733,424.24
Operating Income
592,737.87
592,737.87
778,410.10
1,027,690.53
987,828.03
Net Non Operating Interest Income Expense
69,869.05
69,869.05
55,637.33
4,116.74
3,918.09
Pretax Income
576,379.76
576,379.76
838,071.32
1,030,978.30
1,062,916.89
Tax Provision
110,456.20
110,456.20
124,050.99
138,487.64
144,722.93
Net Income Common Stockholders
465,923.57
465,923.57
714,020.34
892,490.66
918,193.97
Basic EPS
1.41
1.12
1.71
2.34
2.45
Diluted EPS
1.41
1.12
1.71
2.34
2.45
Basic Average Shares
417,362.83
416,003.19
417,555.75
381,406.26
374,773.05
Diluted Average Shares
417,362.83
416,003.19
417,555.75
381,406.26
374,773.05
Total Operating Income as Reported
577,795.56
577,795.56
839,365.74
1,022,695.25
1,083,082.93
Rent Expense Supplemental
561.87
561.87
597.45
21.35
48,725.60
Total Expenses
1,157,365.21
1,157,365.21
1,036,588.53
1,060,352.94
1,007,747.48
Net Income from Continuing & Discontinued Operation
465,923.57
465,923.57
714,020.34
892,490.66
918,193.97
Normalized Income
556,709.86
556,709.86
772,013.14
934,357.59
871,240.97
Interest Income
71,787.42
71,787.42
57,416.30
6,074.02
4,554.82
Interest Expense
1,418.07
1,418.07
1,318.31
1,537.92
--
Net Interest Income
69,869.05
69,869.05
55,637.33
4,116.74
3,918.09
EBIT
577,797.84
577,797.84
839,389.63
1,032,516.23
987,828.03
EBITDA
703,064.40
703,064.40
960,607.53
1,148,615.61
1,058,078.46
Reconciled Cost of Revenue
286,150.20
286,150.20
233,889.73
211,913.42
274,323.25
Reconciled Depreciation
125,266.57
125,266.57
121,217.90
116,099.39
64,840.52
Net Income from Continuing Operation Net Minority Interest
465,923.57
465,923.57
714,020.34
892,490.66
918,193.97
Total Unusual Items Excluding Goodwill
-112,308.94
-112,308.94
-68,068.24
-48,363.42
54,353.59
Total Unusual Items
-112,308.94
-112,308.94
-68,068.24
-48,363.42
54,353.59
Normalized EBITDA
815,373.34
815,373.34
1,028,675.78
1,196,979.03
1,003,724.87
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-21,522.65
-21,522.65
-10,075.43
-6,496.49
7,400.59
12/31/2020 - 10/28/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade